Literature DB >> 16686726

Testosterone levels in men with erectile dysfunction.

José M Martínez-Jabaloyas1, Alfonso Queipo-Zaragozá, Francisco Pastor-Hernández, Manuel Gil-Salom, Pascual Chuan-Nuez.   

Abstract

OBJECTIVE: To investigate the frequency of hypogonadism in men with erectile dysfunction (ED) and to assess which factors are related with low testosterone levels. PATIENTS AND METHODS: In all, 165 men with ED were assessed; the evaluation included: hormonal profiles, serum total and free testosterone (using Vermeulen's formula) levels, and self-reported questionnaires on erectile function and desire domains of the International Index of Erectile Function. The frequency of hypogonadism was established using total and free testosterone levels as diagnostic criteria. The factors that might influence testosterone levels were evaluated by univariate and multivariate statistical analysis, and a logistic regression was used to determine which factors can predict free testosterone levels below normal limits (biochemical hypogonadism).
RESULTS: Using the total testosterone levels, 4.8% of the men were hypogonadal, whereas when using the free testosterone levels, 17.6% were hypogonadal. In the univariate analyses, not smoking and hypertension were associated with lower total and free testosterone levels. Ageing, absence of nocturnal erections and a lower erectile function score were only associated with lower free testosterone serum levels. There was no association between total and free testosterone levels and desire. In the multivariate analysis, only total testosterone levels were related to hypertension, while free testosterone levels were related to age and nocturnal erections. For biochemical hypogonadism, simple logistic regression analysis selected age, erectile function score and aetiological diagnosis of ED as predictors. In the multivariate analysis only the erectile function score had significant independent prognostic value.
CONCLUSIONS: The frequency of hypogonadism is higher when free testosterone levels are used for diagnosis. The total and free testosterone levels were not related to the level of sexual desire in men with ED. The free testosterone levels could be related to the quality and frequency of nocturnal erections, and when ED is more severe, it is more probable that free testosterone levels are below the 'normal' limit.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16686726     DOI: 10.1111/j.1464-410X.2006.06154.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  7 in total

Review 1.  Impact of androgen deprivation therapy on sexual function.

Authors:  Clarisse R Mazzola; John P Mulhall
Journal:  Asian J Androl       Date:  2012-01-09       Impact factor: 3.285

Review 2.  Testosterone and erectile function: from basic research to a new clinical paradigm for managing men with androgen insufficiency and erectile dysfunction.

Authors:  Abdulmaged M Traish; Irwin Goldstein; Noel N Kim
Journal:  Eur Urol       Date:  2007-02-20       Impact factor: 20.096

3.  Influence of serum testosterone on urinary continence and sexual activity in patients undergoing radical prostatectomy for clinically localized prostate cancer.

Authors:  M Gacci; G Corona; G Apolone; A Apolone; M Lanciotti; N Tosi; S Giancane; L Masieri; S Serni; M Maggi; M Carini
Journal:  Prostate Cancer Prostatic Dis       Date:  2010-03-09       Impact factor: 5.554

4.  The relationship of serum and salivary cortisol levels to male sexual dysfunction as measured by the International Index of Erectile Function.

Authors:  Y Kobori; E Koh; K Sugimoto; K Izumi; K Narimoto; Y Maeda; H Konaka; A Mizokami; T Matsushita; T Iwamoto; M Namiki
Journal:  Int J Impot Res       Date:  2009-05-07       Impact factor: 2.896

5.  Markers of erectile dysfunction.

Authors:  Kelvin P Davies; Arnold Melman
Journal:  Indian J Urol       Date:  2008-07

6.  Risk of erectile dysfunction induced by arsenic exposure through well water consumption in Taiwan.

Authors:  Fang-I Hsieh; Ti-Sheng Hwang; Yi-Chen Hsieh; Hsiu-Chiung Lo; Chien-Tien Su; Hui-Shing Hsu; Hung-Yi Chiou; Chien-Jen Chen
Journal:  Environ Health Perspect       Date:  2008-04       Impact factor: 9.031

7.  Development of UK guidance on the management of erectile dysfunction resulting from radical radiotherapy and androgen deprivation therapy for prostate cancer.

Authors:  I D White; J Wilson; P Aslet; A B Baxter; A Birtle; B Challacombe; J Coe; L Grover; H Payne; S Russell; V Sangar; N Van As; M Kirby
Journal:  Int J Clin Pract       Date:  2014-10-06       Impact factor: 2.503

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.